17:17 EST Beta Bionics (BBNX) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBNX:
- Beta Bionics price target lowered to $20 from $40 at Lake Street
- Beta Bionics price target lowered to $14 from $28 at Baird
- Beta Bionics price target lowered to $22 from $25 at Stifel
- Hold Rating Maintained as In-Line Results and Improving Margins Offset Near-Term Prescription Headwinds
- Beta Bionics sees FY26 revenue $130M-$135M, consensus $132.68M